Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose This study was conducted to investigate the prognostic value of lymph node ratio (LNR) instage II/III breast cancer patients who undergo mastectomy after neoadjuvant chemotherapy. Materials and MethodsClinical and pathological data describing stage II/III breast cancer patients were includedin this retrospective study. The primary outcomes were locoregional recurrence-free survival(LRFS), distant metastasis-free survival (DMFS), disease-free survival (DFS), and overallsurvival (OS). ResultsAmong 277 patients, there were 43 ypN0, 64 ypN1, 89 ypN2, and 81 ypN3 cases. Additionally, there were 43, 57, 92 and 85 cases in the LNR 0, 0.01-0.20, 0.21-0.65, and> 0.65 groups, respectively. The median follow-up was 49.5 months. Univariate analysisshowed that both ypN stage and LNR were prognostic factors of LRFS, DMFS, DFS, and OS(p < 0.05). Multivariate analysis showed that LNR was an independent prognostic factor ofLRFS, DMFS, DFS, and OS (p < 0.05), while ypN stage had no effect on prognosis (p > 0.05). ConclusionThe integrated use of LNR and ypN may be suitable for evaluation the prognosis of stageII/III breast cancer patients who undergo mastectomy after neoadjuvant chemotherapy.
Abstract
Purpose This study was conducted to investigate the prognostic value of lymph node ratio (LNR) instage II/III breast cancer patients who undergo mastectomy after neoadjuvant chemotherapy. Materials and MethodsClinical and pathological data describing stage II/III breast cancer patients were includedin this retrospective study. The primary outcomes were locoregional recurrence-free survival(LRFS), distant metastasis-free survival (DMFS), disease-free survival (DFS), and overallsurvival (OS). ResultsAmong 277 patients, there were 43 ypN0, 64 ypN1, 89 ypN2, and 81 ypN3 cases. Additionally, there were 43, 57, 92 and 85 cases in the LNR 0, 0.01-0.20, 0.21-0.65, and> 0.65 groups, respectively. The median follow-up was 49.5 months. Univariate analysisshowed that both ypN stage and LNR were prognostic factors of LRFS, DMFS, DFS, and OS(p < 0.05). Multivariate analysis showed that LNR was an independent prognostic factor ofLRFS, DMFS, DFS, and OS (p < 0.05), while ypN stage had no effect on prognosis (p > 0.05). ConclusionThe integrated use of LNR and ypN may be suitable for evaluation the prognosis of stageII/III breast cancer patients who undergo mastectomy after neoadjuvant chemotherapy.
참고문헌 (24)
- Mauri D, "Neoadjuvant versus adjuvant systemic treatment in breast cancer : a meta-analysis", J Natl Cancer Inst, 97, pp.188~194 (2005)
- Kaufmann M, "International expert panel on the use of primary(preoperative)systemic treatment of operable breast cancer : review and recommendations", J Clin Oncol, 21, pp.2600~2608 (2003)
- Estevez LG, "Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancer", Clin Cancer Res, 10, pp.3249~3261 (2004)
- Shimizu C, "Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer", Jpn J Clin Oncol, 37, pp.1~8 (2007)
- Keam B, "Clinical significance of axillary nodal ratio in stage II", III breast cancer treated with neoadjuvant chemotherapy, 2009, pp.116, 153~160
- Fisher B, "Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer : findings from National Surgical Adjuvant Breast and Bowel Project B-18", J Clin Oncol, 15, pp.2483~2493 (1997)
- Baslaim MM, "Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy", Am J Surg, 184, pp.299~301 (2002)
- Belanger J, "Neoadjuvant chemotherapy in invasive breast cancer results in a lower axillary lymph node count", J Am Coll Surg, 206, pp.704~708 (2008)
- Neuman H, "Axillary lymph node count is lower after neoadjuvant chemotherapy", Am J Surg, 191, pp.827~829 (2006)
- Vinh-Hung V, "Lymph node ratio as an alternative to pN staging in node-positive breast cancer", J Clin Oncol, 27, pp.1062~1068 (2009)
- Danko ME, "Improved staging in node-positive breast cancer patients using lymph node ratio : results in 1, 788 patients with longterm follow-up", J Am Coll Surg, 210, pp.797~805 (2010)
- Chagpar AB, "Lymph node ratio should be considered for incorporation into staging for breast cancer", Ann Surg Oncol, 18, pp.3143~3148 (2011)
- Ahn SH, "Lymph node ratio and pN staging in patients with nodepositive breast cancer : a report from the Korean breast cancer society", Breast Cancer Res Treat, 130, pp.507~515 (2011)
- Wu SG, "Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy", Radiat Oncol, 8, pp.119~ (2013)
- Wu SG, "Prognostic value of metastatic axillary lymph node ratio for Chinese breast cancer patients", PLoS One, 8, pp.e61410~ (2013)
- Goldhirsch A, "Strategies for subtypes: dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011", Ann Oncol, 22, pp.1736~1747 (2011)
- Houssami N, "Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy", Eur J Cancer, 48, pp.3342~3354 (2012)
- Saxena N, "Prognostic value of axillary lymph node status after neoadjuvant chemotherapy : Results from a multicentre study", Eur J Cancer, 47, pp.1186~1192 (2011)
- Jeruss JS, "Staging of breast cancer in the neoadjuvant setting", Cancer Res, 68, pp.6477~6481 (2008)
- Veronesi U, "Rethinking TNM : a breast cancer classification to guide to treatment and facilitate research", Breast J, 15, pp.291~295 (2009)
- Truong PT, "The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center", Int J Radiat Oncol Biol Phys, 68, pp.59~65 (2007)
- Castrucci W, "Using nodal ratios to predict risk of regional recurrences in patients treated with breast conservation therapy with 4 or more positive lymph nodes", ISRN Surg, 2011, pp.874814~ (2011)
- Vinh-Hung V, "Prognostic value of nodal ratios in node-positive breast cancer : a compiled update", Future Oncol, 5, pp.1585~1603 (2009)
- Woodward WA, "Prognostic value of nodal ratios in node-positive breast cancer", J Clin Oncol, 24, pp.2910~2916 (2006)